115 related articles for article (PubMed ID: 34738816)
1. Intelligent Pore Switch of Hollow Mesoporous Organosilica Nanoparticles for High Contrast Magnetic Resonance Imaging and Tumor-Specific Chemotherapy.
Huang L; Feng J; Fan W; Tang W; Rong X; Liao W; Wei Z; Xu Y; Wu A; Chen X; Shen Z
Nano Lett; 2021 Nov; 21(22):9551-9559. PubMed ID: 34738816
[TBL] [Abstract][Full Text] [Related]
2. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable hollow mesoporous organosilica nanotheranostics (HMONs) as a versatile platform for multimodal imaging and phototherapeutic-triggered endolysosomal disruption in ovarian cancer.
Li P; Lin B; Chen Z; Liu P; Liu J; Li W; Liu P; Guo Z; Chen C
Drug Deliv; 2022 Dec; 29(1):161-173. PubMed ID: 34967262
[TBL] [Abstract][Full Text] [Related]
4. Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System.
Hu M; Zhang W; Chen W; Chen Y; Huang Q; Bao Q; Lin T; Wang L; Zhang S
AAPS PharmSciTech; 2022 Jun; 23(6):180. PubMed ID: 35761120
[TBL] [Abstract][Full Text] [Related]
5. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer.
Guo W; Chen Z; Chen J; Feng X; Yang Y; Huang H; Liang Y; Shen G; Liang Y; Peng C; Li Y; Li G; Huang W; Zhao B; Hu Y
J Nanobiotechnology; 2020 Jul; 18(1):99. PubMed ID: 32690085
[TBL] [Abstract][Full Text] [Related]
7. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
8. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.
Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X
ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749
[TBL] [Abstract][Full Text] [Related]
9. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
Fan J; Zhang Z; Wang Y; Lin S; Yang S
J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
11. Chemodrug-Gated Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Multimodal Imaging-Guided Low-Temperature Photothermal Therapy/Chemotherapy of Cancer.
Wu J; Bremner DH; Niu S; Shi M; Wang H; Tang R; Zhu LM
ACS Appl Mater Interfaces; 2018 Dec; 10(49):42115-42126. PubMed ID: 30462492
[TBL] [Abstract][Full Text] [Related]
12. Multi-stimuli responsive hollow MnO
Xu X; Duan J; Liu Y; Kuang Y; Duan J; Liao T; Xu Z; Jiang B; Li C
Acta Biomater; 2021 May; 126():445-462. PubMed ID: 33785453
[TBL] [Abstract][Full Text] [Related]
13. Hollow mesoporous organosilica nanotheranostics incorporating formimidoyltransferase cyclodeaminase (FTCD) plasmids for magnetic resonance imaging and tetrahydrofolate metabolism fission on hepatocellular carcinoma.
Chen J; Yang Y; Lin B; Xu Z; Yang X; Ye S; Xie Z; Li Y; Hong J; Huang Z; Huang W
Int J Pharm; 2022 Jan; 612():121281. PubMed ID: 34774692
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted Gd-doped mesoporous Fe
Zheng S; Jin S; Jiao M; Wang W; Zhou X; Xu J; Wang Y; Dou P; Jin Z; Wu C; Li J; Ge X; Xu K
Drug Deliv; 2021 Dec; 28(1):787-799. PubMed ID: 33866915
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-hybridized mesoporous organosilica nanoparticles with high magnetic resonance imaging performance for targeted drug delivery.
Zhang J; Su X; Weng L; Tang K; Miao Y; Teng Z; Wang L
J Colloid Interface Sci; 2023 Mar; 633():102-112. PubMed ID: 36436344
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable organosilica magnetic micelles for magnetically targeted MRI and GSH-triggered tumor chemotherapy.
Yang T; Niu D; Chen J; He J; Yang S; Jia X; Hao J; Zhao W; Li Y
Biomater Sci; 2019 Jun; 7(7):2951-2960. PubMed ID: 31099352
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable and biocompatible monodispersed hollow mesoporous organosilica with large pores for delivering biomacromolecules.
Zhang L; Wang L; Yao H; Xu F; Chen Y
J Mater Chem B; 2017 Oct; 5(39):8013-8025. PubMed ID: 32264202
[TBL] [Abstract][Full Text] [Related]
18. Redox/Near-Infrared Dual-Responsive Hollow Mesoporous Organosilica Nanoparticles for Pesticide Smart Delivery.
Wang K; Li JQ; He S; Lu J; Wang D; Wang JX; Chen JF
Langmuir; 2023 Dec; 39(50):18466-18475. PubMed ID: 38054693
[TBL] [Abstract][Full Text] [Related]
19. Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.
Liu L; Xu X; Liang X; Zhang X; Wen J; Chen K; Su X; Ma Y; Teng Z; Lu G; Xu J
J Colloid Interface Sci; 2021 Jun; 591():211-220. PubMed ID: 33609893
[TBL] [Abstract][Full Text] [Related]
20. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin.
Asghar K; Qasim M; Dharmapuri G; Das D
Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
